Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on November 25, 2008
JNCI Journal of the National Cancer Institute 2008 100(23):1660-1661; doi:10.1093/jnci/djn413
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/23/1660    most recent
djn413v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Walsh, C. S.
Right arrow Articles by Karlan, B. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walsh, C. S.
Right arrow Articles by Karlan, B. Y.
Related Collections
Right arrowRelated Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

EDITORIALS

Lymphadenectomy's Role in Early Endometrial Cancer: Prognostic or Therapeutic?

Christine S. Walsh, Beth Y. Karlan

Affiliations of authors: Women's Cancer Research Institute, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (CSW, BYK)

Correspondence to: Beth Y. Karlan, Women's Cancer Research Institute, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd, #290W, Los Angeles, CA 90048 (e-mail: karlanb@cshs.org).

The first 10% of the full text of this article appears below.

In 1988, endometrial cancer became a surgically staged disease. Because frequent inaccuracies in clinical staging were recognized, the International Federation of Gynecology and Obstetrics introduced a new surgicopathologic staging system that emphasized the prognostic value of surgical staging information (1). Largely on the basis of the seminal findings of the Gynecologic Oncology Group (GOG) 33 trial (2), surgical staging was introduced that incorporated pathological risk factors to better define the extent of disease, estimate prognosis, and guide adjuvant treatment recommendations. Despite implementation of this more accurate staging system, optimal treatment for the management of endometrial cancer remains controversial, particularly in patients with intermediate-risk disease, which . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

Pelvic Lymphadenectomy Does Not Improve Survival in Early-stage Endometrial Cancer
J Natl Cancer Inst 2008 100: 1657. [Extract] [Full Text] [PDF]